Change in calculated cardiovascular risk due to guideline revision: A cross-sectional study in the Netherlands

REFERENCES

• National Heart Foundation of Australia. Hypertension management guide for doctors 2004. Canberra: Heart Foundation; 2004. pp. 24. Available at: http://www.schta.cat/arxius/guias/hypertension_management_guide_2004.pdf (accessed 2 September 2014).
   Google Scholar
• National Heart Foundation of Australia (National Blood Pressure and Vascular Disease Advisory Committee). Guide to management of hypertension 2008. Updated December 2010. Canberra: Heart Foundation; 2010. pp. 30. Available at: https://www.clinicalguidelines.gov.au/search.php?pageType=2&fldglrID=1817& (accessed 2 September 2014).
   Google Scholar
• Newcastle guideline Development and Research Unit; the section on prescribing drugs has been updated by the British Hypertension Society and the National Collaborating Centre for Chronic Conditions. Hypertension Management of hypertension in adults in primary care. London: National Institute for Health and Clinical Excellence; 2006. pp. 45.
   Google Scholar
• Newcastle Guideline Development and Research Unit. Updated by the National Clinical Guideline Centre (formerly the National Collaborating Centre for Chronic Conditions) and the British Hypertension Society. Hypertension. Clinical management of primary hypertension in adults. London: National Institute for Health and Clinical Excellence; 2011. pp. 38. Available at: https://www.nice.org.uk/guidance/cg127/resources/guidance-hypertension-pdf (accessed 2 September 2014).
   Google Scholar
• New Zealand Guidelines Group. New Zealand cardiovascular guidelines handbook. 2nd ed. Wellington: New Zealand Guidelines Group; 2009. pp. 92.
   Google Scholar
• Cardiovascular Disease Risk Assessment Steering Group. New Zealand primary care handbook 2012. Wellington: Ministry of Health; 2013. pp. 22. Available at: http://www.health.govt.nz/publication/new-zealand-primary-care-handbook-2012 (accessed 2 September 2014).
   Google Scholar
• Graham I, Atar D, Borch-Johnsen K, Boysen G, Burell G, Cifkova R, et al. European guidelines on cardiovascular disease prevention in clinical practice: Full text. Fourth Joint Task Force of the European Society of Cardiology and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of nine societies and by invited experts). Eur J Cardiovasc Prev Rehabil. 2007;14(Suppl.2):S1–113.
   PubMed Web of Science ®Google Scholar
• Perk J, De Backer G, Gohlke H, Graham I, Reiner Z, Verschuren M, et al. European Guidelines on cardiovascular disease prevention in clinical practice (version 2012). The Fifth Joint Task Force of the European Society of Cardiology and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of nine societies and by invited experts). Eur Heart J. 2012;33:1635–701.
   PubMed Web of Science ®Google Scholar
• Gohlke H, Albus C, Bönner G, Darius H, Eckert S, Gerber A, et al. Risikoadjustierte prävention von herz-und kreislauferkrankungen. Düsseldorf: Vorstand der Deutschen Gesellschaft für Kardiologie—Herz-und Kreislaufforschung eV; 2007. pp. 39. Available at: http://leitlinien.dgk.org/files/2007_Pocket-Leitlinien_Risikoadjustierte_Praevention.pdf (accessed 2 September 2014).
   Google Scholar
• Gohlke H, Gielen S, König W, Schuler G, Rauch B, Sonntag F. ESC pocket guidelines prävention von herz-kreislauf-erkrankungen. Düsseldorf: Deutsche Gesellschaft für Kardiologie—Herz-und Kreislauf Forschung eV (DGK); 2012. pp. 31. Available at: http://leitlinien.dgk.org/files/PL_Pr%C3%A4vention_Internet_13.pdf (accessed 2 September 2014).
   Google Scholar
• Robson J. Lipid modification: Cardiovascular risk assessment and the modification of blood lipids for the primary and secondary prevention of cardiovascular disease. Heart 2008;94:1331–2.
   PubMed Web of Science ®Google Scholar
• Rabar S, Harker M, O’Flynn N, Wierzbicki AS. Lipid modification and cardiovascular risk assessment for the primary and secondary prevention of cardiovascular disease: Summary of updated NICE guidance. Br Med J. 2014;349:g4356.
   PubMed Web of Science ®Google Scholar
• Rosendorff C, Black HR, Cannon CP, Gersh BJ, Gore J, Izzo JL, Jr, et al. Treatment of hypertension in the prevention and management of ischemic heart disease: A scientific statement from the American Heart Association council for high blood pressure research and the councils on clinical cardiology and epidemiology and prevention. Circulation 2007;115:2761–88.
   PubMed Web of Science ®Google Scholar
• Weintraub WS, Daniels SR, Burke LE, Franklin BA, Goff DC, Jr, Hayman LL, et al. Value of primordial and primary prevention for cardiovascular disease: A policy statement from the American Heart Association. Circulation 2011;124:967–90.
   PubMed Web of Science ®Google Scholar
• Walma EP, Thomas S, Prins A, Grundmeijer HG, Van der Laan JR, Wiersma T. NHG-standaard hypertensie. Huisarts en Wetenschap. 2003;46:435–49.
   Google Scholar
• Thomas S, van der Weijden T, van Drenth BB, Haverkort AF, Hooi JD, van der Laan JR. NHG-standaard cholesterol. Utrecht: Nederlands Huisartsen Genootschap; 1999. pp. 6 .
   Google Scholar
• Ärztliche Zentralstelle Qualitätssicherung. Leitlinien-Clearing-Bericht ‘Hypertonie‘. Köln: Ärztliche Zentralstelle Qualitätssicherung; 2000. pp. 167. Available at: http://www.leitlinien.de/mdb/edocs/pdf/schriftenreihe/schriftenreihe5.pdf (accessed 2 September 2014).
   Google Scholar
• Burgers JS, Simoons ML, Hoes AW, Stehouwer CD, Stalman WA. Guideline ‘cardiovascular risk management’. Ned Tijdschr Geneeskd. 2007;151:1068–74.
   PubMedGoogle Scholar
• De Backer G, Ambrosioni E, Borch-Johnsen K, Brotons C, Cifkova R, Dallongeville J, et al. European guidelines on cardiovascular disease prevention in clinical practice. Third Joint Task Force of European and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of eight societies and by invited experts). Atherosclerosis 2004;173:381–91.
   PubMed Web of Science ®Google Scholar
• Wiersma T, Smulders YM, Stehouwer CD, Konings KT, Lanphen J. Summary of the multidisciplinary guideline on cardiovascular risk management (revision 2011). Ned Tijdschr Geneeskd 2012; 156:A5104.
   PubMedGoogle Scholar
• van den Dungen C, Hoeymans N, Gijsen R, van den Akker M, Boesten J, Brouwer H, et al. What factors explain the differences in morbidity estimations among general practice registration networks in the Netherlands? A first analysis. Eur J Gen Pract. 2008;14S1:53–62.
   Google Scholar
• http://www.atccode.com/ (accessed 11 May 2015).
   Google Scholar
• https://www.nhg.org/sites/default/files/content/nhg_org/uploads/icpc-versie-4-inkijkexemplaar_0.pdf (accessed 11 May 2015).
   Google Scholar
• Schafer JL. Multiple imputation: A primer. Stat Methods Med Res. 1999;8:3–15.
   PubMed Web of Science ®Google Scholar
• Bij S, Biermans M, Khan N, Akkermans R, Peters H, Levelink H, et al. De kwaliteit van de verslaglegging in medische dossiers: Uitbreiding van de EPD-scan. Regio Nijmegen, eerste meting. Utrecht: Nivel; 2013. pp. 91. Available at: http://www.nivel.nl/sites/default/files/bestanden/Rappport-kwaliteit-verslaglegging-medische-dossiers.pdf? (accessed 2 September 2014).
   Google Scholar
• van Duijn HJ, Belo JN, Blom JW, Velberg ID, Assendelft WJ. Revised guidelines for cardiovascular risk management—time to stop medication? A practice-based intervention study. Br J Gen Pract. 2011;61:e347–e52.
   PubMed Web of Science ®Google Scholar
• Scheltens T, Verschuren WM, Boshuizen HC, Hoes AW, Zuithoff NP, Bots ML, et al. Estimation of cardiovascular risk: A comparison between the Framingham and the SCORE model in people under 60 years of age. Eur J Cardiovasc Prev Rehabil. 2008;15:562–6.
   PubMed Web of Science ®Google Scholar
• Pyorala K, De Backer G, Graham I, Poole-Wilson P, Wood D. Prevention of coronary heart disease in clinical practice. Recommendations of the Task Force of the European Society of Cardiology, European Atherosclerosis Society and European Society of Hypertension. Eur Heart J. 1994;15:1300–31.
   PubMed Web of Science ®Google Scholar